ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,992Medicare Part D Prescriptions Filled, Including Refills

Rank: 128 out of 680

$875K Total Retail Price of All Prescriptions

Rank: 111 out of 680

552 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 552 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

18% of this provider’s 552 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 10,787 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
SIMVASTATIN 586 507 1 3
AMLODIPINE BESYLATE 452 384 2 1
HYDROCODONE-ACETAMINOPHEN 443 323 S3 3 4
CARVEDILOL 392 324 4 23
LISINOPRIL 355 252 5 5
LEVOTHYROXINE SODIUM 352 299 6 2
METFORMIN HCL 302 234 7 8
PRAVASTATIN SODIUM 281 239 8 10
FUROSEMIDE 261 201 9 6
BENAZEPRIL HCL 255 198 10 40
ZOLPIDEM TARTRATE 242 188 11 17
ALLOPURINOL 237 176 12 33
GLIMEPIRIDE 229 180 13 29
FLUTICASONE PROPIONATE 212 151 14 41
METOPROLOL SUCCINATE 201 178 15 13
OMEPRAZOLE 197 99 16 7
CITALOPRAM HBR 175 154 17 22
METFORMIN HCL ER 164 137 18 54
AZELASTINE HCL 159 110 19 240
SPIRONOLACTONE 142 115 20 82
GABAPENTIN 142 113 20 15
TRAMADOL HCL 139 92 22 18
CRESTOR 138 117 23 25
EVISTA 136 109 24 135
WARFARIN SODIUM 131 111 25 20
ATORVASTATIN CALCIUM 130 86 26 11
NEXIUM 121 88 27 16
NAPROXEN 112 82 28 121
CYCLOBENZAPRINE HCL 103 41 R 29 81
CLOPIDOGREL 103 93 29 26
LOSARTAN POTASSIUM 100 86 31 21
CLONIDINE HCL 99 77 32 36
HYDRALAZINE HCL 94 82 33 71
DIGOXIN 90 72 34 58
LISINOPRIL-HYDROCHLOROTHIAZIDE 90 69 34 37
POTASSIUM CHLORIDE 88 69 36 14
TRIAMTERENE-HCTZ 87 59 37 52
DONEPEZIL HCL 86 74 38 27
NAMENDA 85 80 39 35
DIOVAN HCT 85 73 39 55
TAMSULOSIN HCL 80 60 41 34
DOXEPIN HCL 80 48 41 200
DIOVAN 78 57 43 31
AMITRIPTYLINE HCL 77 50 R 44 47
FENOFIBRATE 75 61 45 66
METOPROLOL TARTRATE 74 73 46 12
AZITHROMYCIN 74 56 46 42
PANTOPRAZOLE SODIUM 72 60 48 30
INSULIN SYRINGE 70 48 49 86
PLAVIX 69 64 50 39
DOXAZOSIN MESYLATE 68 56 51 73
LEVETIRACETAM 66 43 52 120
POLYETHYLENE GLYCOL 3350 66 53 52 62
HUMULIN 70-30 64 54 54 277
TRAZODONE HCL 61 44 55 48
MEGESTROL ACETATE 60 59 R 56 88
SYNTHROID 60 41 56 38
FAMOTIDINE 58 42 58 89
ATENOLOL 58 48 58 19
LOSARTAN-HYDROCHLOROTHIAZIDE 57 51 60 51
CYMBALTA 57 40 60 46
AMLODIPINE BESYLATE-BENAZEPRIL 57 46 60 43
MIRTAZAPINE 56 52 63 78
FINASTERIDE 56 56 63 109
ALENDRONATE SODIUM 54 47 65 32
NATEGLINIDE 52 46 66 224
ISOSORBIDE MONONITRATE ER 52 52 66 59
PREDNISONE 50 31 68 50
HYDROCHLOROTHIAZIDE 50 38 68 9
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 14, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.